CQ39. Should Relapsed Lesions of Differentiated Carcinoma That Were Diagnosed as Anaplastic Carcinoma Be Treated as Anaplastic Carcinoma?



It is empirically known that anaplastic transformation can be recognized in relapsed lesions of differentiated carcinoma. In this CQ, risk factors for anaplastic transformation and its clinical behavior, standard treatment for such cases, and treatment results are discussed.


Palliative Care Thyroid Carcinoma External Beam Radiotherapy Anaplastic Carcinoma Superior Vena Cava Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ozaki O, Ito K, Mimura T et al (1999) Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study. J Surg Oncol 70:45–48 (CaseR)PubMedCrossRefGoogle Scholar
  2. 2.
    Kitamura Y, Shimizu K, Nagahama M et al (1999) Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 84:4043–4049 (RS)PubMedCrossRefGoogle Scholar
  3. 3.
    Ozumi S, Takashima N, Bandai K et al (1996) (Text in Japanese) Ganno Rinsho 42:267–272 (RS)Google Scholar
  4. 4.
    Brabant G, Maenhaut C, Kohrle J et al (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–R12 (Others)PubMedCrossRefGoogle Scholar
  5. 5.
    Wiseman SM, Griffith OL, Deen S et al (2007) Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg 142:717–727, discussion 727–729 (Others)PubMedCrossRefGoogle Scholar
  6. 6.
    Ito Y, Higashiyama T, Hirokawa M et al (2008) Prognosis of patients with papillary carcinoma showing anaplastic transformation in regional lymph nodes that were curatively resected. Endocr J 55:985–989 (CaseR)PubMedCrossRefGoogle Scholar
  7. 7.
    Shaha AR (2008) Airway management in anaplastic thyroid carcinoma. Laryngoscope 118:1195–1198 (RS)PubMedCrossRefGoogle Scholar
  8. 8.
    Takano T, Ito Y, Hirokawa M (2007) BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. Br J Cancer 96:1549–1553 (Others)PubMedCrossRefGoogle Scholar
  9. 9.
    Wang HM, Huang YW, Huang JS et al (2007) Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol 14:3011–3018 (Others)PubMedCrossRefGoogle Scholar
  10. 10.
    Nakamura T, Yana I, Kobayashi T (1992) p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83:1293–1298 (Others)PubMedCrossRefGoogle Scholar
  11. 11.
    Bond JA, Oddweig Ness G, Rowson J et al (1996) Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression? Int J Cancer 67:563–572 (Others)PubMedCrossRefGoogle Scholar
  12. 12.
    Hunt JL, Tometsko M, LiVolsi VA et al (2003) Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 27:1559–1564 (Others)PubMedCrossRefGoogle Scholar
  13. 13.
    Aratake Y, Nomura H, Kotani T et al (2006) Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 125:399–406 (Others)Google Scholar
  14. 14.
    Wiseman SM, Masoudi H, Niblock P et al (2006) Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg 191:581–587 (Others)PubMedCrossRefGoogle Scholar
  15. 15.
    Wallin G, Bäckdahl M, Tallroth-Ekman E (1989) Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study. Eur J Surg Oncol 15:43–48 (RS)PubMedGoogle Scholar
  16. 16.
    Wiseman SM, Loree TR, Hicks WL Jr et al (2003) Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg 129:96–100 (Others)PubMedCrossRefGoogle Scholar
  17. 17.
    Rodrigues RF, Roque L, Rosa-Santos J (2004) Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer 90:492–496 (Others)PubMedCrossRefGoogle Scholar
  18. 18.
    Salvatore G, Nappi TC, Salerno P et al (2007) A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res 67:10148–10158 (Others)PubMedCrossRefGoogle Scholar
  19. 19.
    O’Neill JP, O’Neill B, Condron C et al (2005) Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease. J Laryngol Otol 119:585–591 (NR)PubMedGoogle Scholar
  20. 20.
    Thyroid Carcinoma Task Force (2001) AACE/AAES Medical/Surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202–220 (Others)Google Scholar
  21. 21.
    Singer PA, Cooper DS, Daniels GH et al (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165–2172 (Others)PubMedCrossRefGoogle Scholar
  22. 22.
    Sherman SI, Angelos P, Ball DW et al (2009) National comprehensive cancer network. Clinical practice guidelines in oncology-v.1. Thyroid carcinoma. http://www.nccn.org/(on line) (Others)

Copyright information

© Springer Japan 2013

Authors and Affiliations

  1. 1.Department of SurgeryIto HospitalTokyoJapan
  2. 2.Department of Surgical OncologyOsaka City University Graduate School of MedicineOsakaJapan

Personalised recommendations